paclitaxel has been researched along with puerarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Wang, R; Wu, Y | 1 |
| Chen, X; Huang, J; Kang, Y; Wu, J; Xiong, H; Yi, T | 1 |
2 other study(ies) available for paclitaxel and puerarin
| Article | Year |
|---|---|
Puerarin suppresses TRPV1, calcitonin gene-related peptide and substance P to prevent paclitaxel-induced peripheral neuropathic pain in rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calcitonin Gene-Related Peptide; Isoflavones; Male; Neuralgia; Paclitaxel; Rats; Rats, Sprague-Dawley; Substance P; TRPV Cation Channels | 2019 |
Synthesis, characterization, and formulation of poly-puerarin as a biodegradable and biosafe drug delivery platform for anti-cancer therapy.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Drug Liberation; Female; Humans; Hydrophobic and Hydrophilic Interactions; Isoflavones; Mice; Nanoparticles; Paclitaxel; Safety | 2019 |